Tired of ads? Enjoy an ad-free experience by signing up.
Daniel Ren · · 2 min read

Investors hunt for gold ahead of debut of China’s Nasdaq-like tech board

Mainland investors are racing to buy mutual funds linked to Shanghai’s new Nasdaq-style technology board in the expectation that these funds will have privileged access to upcoming initial public offerings, potentially enjoying handsome returns upon public trading.

Flag of China downtrend stock data diagram

Photo credit: nk2549 / 123RF

As of Tuesday, the first batch of seven funds slated for the Technology Innovation Board were heavily oversubscribed by investors, raising a combined 100 billion yuan (US$14.86 billion), according to the statements by the asset management firms.

“Optimism about the trading outlook for the technology firms resulted in strong sales of the funds,” said Ivan Li, an asset manager with hedge fund Loyal Wealth Management. “Mainland investors have faith in IPO shares and they are convinced that the companies set to list on the new technology board will bring them handsome returns.”

Mainland mutual fund houses can issue new products to raise funds subject to the approval by the China Securities Regulatory Commission (CSRC).

The country’s largest fund management firms including China Asset Management and China Southern Asset Management were among the first institutions allowed to launch funds that focus on the new board.

Six of the first seven funds were at least 10x oversubscribed, while the fund launched by China Asset Management received 25x more orders than it was able to fulfill.

The seven funds approved so far can all subscribe to the retail portion of new shares offered on the technology board, while one fund will also have access to the institutional tranche.

Another 70 funds are awaiting approval from the CSRC.

Beijing is expected to launch the board in the middle of this year.

The new board, touted by regulators as another milestone in the country’s capital markets, allows unprofitable technology firms and pre-revenue biotechnology companies to list on the Shanghai Stock Exchange.

The applicants thus far are mainly engaged in microchip making, computers, robotics, new materials and life sciences.

Companies listing on the new board can trade freely for the first five days and will be subject to a 20% limit before trade is halted from the sixth day of trade.

Companies that debut on the regular Shanghai board are allowed to trade without limit on the first day, and thereafter are allowed to rise or fall by 10% before trade is halted.

Stay ahead in Asia’s tech landscape

You've reached your 2 free content limit for the month. Sign up for free to read the full story.

🏄 For casual readers / 👶 Free

Basic

US$0

Free forever

Get instant access to this article and more every month

0 premium content

Unlimited news briefs

5

5 articles

Ad-free reading experience

Just US$0 per day

⌛Sign up in 20s. No payment details needed.

📖 For learners / 👍 Starter

Lite

US$4.92/month

Billed annually at US$59/year

Get instant access to this article and more every month

4

4 premium content

Unlimited news briefs & articles

Ad-free reading experience

Just US$0.17 per day

Cancel anytime

Our subscriber community includes professionals from these companies:

Stay updated on the go with our mobile app.

Get latest insights with smoother, more personalized experience through TIA mobile app.

Community Writer

Daniel Ren

Daniel Ren is the Post's Shanghai bureau chief. A Shanghai native, Daniel joined the Post in 2007 as a business reporter.